Regencell Bioscience
RGC
trading on NASDAQ
since 2021
$74.00
(Δ 372.53%)
+$58.34 since open
Regencell Bioscience Limited specializes in developing innovative regenerative medicine solutions, including cell therapy products aimed at improving health outcomes.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $26.20 | $83.60 | $26.20 | $8.33B | 5.29M |
| eps | p/e | p/s |
operating margin |
profit margin |
yield |
| +$0.07 | 92.50 | 16.21 | 3.14% | 1.59% | 1.19% |